Bonk (NASDAQ:BNKK) Director Mitchell Austin Rudy Purchases 12,000 Shares

Posted by Stanley Muller on Jun 17th, 2026

Bonk, Inc. (NASDAQ:BNKK – Get Free Report) Director Mitchell Austin Rudy acquired 12,000 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were bought at an average cost of $1.37 per share, for a total transaction of $16,440.00. Following the transaction, the director directly owned 63,341 shares in the company, valued at approximately $86,777.17. This represents a 23.37% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Mitchell Austin Rudy also recently made the following trade(s):

On Thursday, April 9th, Mitchell Austin Rudy bought 31,055 shares of Bonk stock. The stock was purchased at an average cost of $2.82 per share, with a total value of $87,575.10.

Bonk Stock Performance

BNKK stock opened at $1.33 on Wednesday. The stock’s 50 day simple moving average is $2.21 and its 200 day simple moving average is $3.18. The company has a market cap of $10.64 million, a P/E ratio of -0.29 and a beta of 1.85. Bonk, Inc. has a fifty-two week low of $1.25 and a fifty-two week high of $46.90.

Bonk (NASDAQ:BNKK – Get Free Report) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.23) EPS for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%. The firm had revenue of $0.79 million during the quarter.

Analyst Upgrades and Downgrades

BNKK has been the topic of a number of analyst reports. Weiss Ratings lowered shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. Wall Street Zen upgraded Bonk from a “sell” rating to a “hold” rating in a report on Saturday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Check Out Our Latest Research Report on BNKK

Hedge Funds Weigh In On Bonk

Institutional investors have recently modified their holdings of the business. Geode Capital Management LLC purchased a new stake in shares of Bonk during the fourth quarter valued at approximately $128,000. Jane Street Group LLC bought a new position in Bonk in the 4th quarter valued at $96,000. Steward Partners Investment Advisory LLC purchased a new stake in shares of Bonk during the 4th quarter valued at $37,000. Finally, State Street Corp bought a new stake in shares of Bonk during the 4th quarter worth $33,000. 12.55% of the stock is owned by institutional investors.

Bonk Company Profile

(Get Free Report)

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.